A pioneering platform focused on developing peptides that normalize cellular iron microenvironments, progressing into supplementary co-therapies for hormone-sensitive cancers and neurological disorders associated with iron dysregulation
FIRST THERAPEUTIC TARGETA novel co-treatment for Prostate Cancer
SITE UNDER CONSTRUCTION